Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 December;58(4) > Panminerva Medica 2016 December;58(4): 349-50

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2016 December;58(4): 349-50

language: English

Extension of the stability of anticancer drugs in pharmaceutical practice

Francesca BARATTA 1, Franca GOFFREDO 2, Laura ANNARATONE 3, Anna SAPINO 3, Oscar BERTETTO 4, Paola BRUSA 1

1 Department of Science and Pharmaceutical Technology, University of Turin, Turin, Italy; 2 Oncology Foundation of Piedmont Region, Institute for Cancer Research and Treatment (IRCC), Candiolo, Turin, Italy; 3 Department of Medical Sciences, University of Turin, Turin, Italy; 4 Interaziendale Interregionale Rete Oncologica Piemonte e Valle d’Aosta Department, A.O.U. Città della Salute e della Scienza, Turin, Italy


PDF  


top of page

Publication History

Cite this article as

Corresponding author e-mail

francesca.baratta@unito.it